基于分层端点的Win测量的样本量和功率计算。

IF 1.8 4区 医学 Q3 MATHEMATICAL & COMPUTATIONAL BIOLOGY
Huiman Barnhart, Yuliya Lokhnygina, Roland Matsouaka, Susan Halabi, David Yanez, Robert J Mentz, Frank Rockhold
{"title":"基于分层端点的Win测量的样本量和功率计算。","authors":"Huiman Barnhart, Yuliya Lokhnygina, Roland Matsouaka, Susan Halabi, David Yanez, Robert J Mentz, Frank Rockhold","doi":"10.1002/sim.70096","DOIUrl":null,"url":null,"abstract":"<p><p>Win measures, such as win ratio, win odds, net benefit, and desirability of outcome ranking (DOOR), have become popular approaches for the analysis of hierarchical endpoints in clinical studies. Sample size and power calculations with win measures based on hierarchical endpoints are often based on simulation studies that can be cumbersome. Existing sample size and power formulas require investigators to specify clinically significant and meaningful magnitudes of win measures and probability of ties that are difficult to elicit based on prior published literature or preliminary data. In this paper, we provide sample size and power calculation formulas for the four win measures. To facilitate the formula-based sample size or power calculations, we provide formulas to compute overall win measures and overall probability of ties needed by using the specification of marginal win measures and marginal probability of ties that are readily available from clinical investigators or literature. The latter formulas provide a novel way to specify a meaningful and justifiable magnitude of win measures and the magnitude of probability of ties. Therefore, they can be readily used to evaluate the powers based on the number of multiple endpoints, the ordering, and types of endpoints. Our extensive simulation studies show that the power estimations based on these formulas are often like the simulated powers for any type of correlated hierarchical endpoints except for scenarios with very high correlations between endpoints. We illustrate the usefulness of our formulas by using data from three trials with different types of hierarchical endpoints.</p>","PeriodicalId":21879,"journal":{"name":"Statistics in Medicine","volume":"44 10-12","pages":"e70096"},"PeriodicalIF":1.8000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sample Size and Power Calculations With Win Measures Based on Hierarchical Endpoints.\",\"authors\":\"Huiman Barnhart, Yuliya Lokhnygina, Roland Matsouaka, Susan Halabi, David Yanez, Robert J Mentz, Frank Rockhold\",\"doi\":\"10.1002/sim.70096\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Win measures, such as win ratio, win odds, net benefit, and desirability of outcome ranking (DOOR), have become popular approaches for the analysis of hierarchical endpoints in clinical studies. Sample size and power calculations with win measures based on hierarchical endpoints are often based on simulation studies that can be cumbersome. Existing sample size and power formulas require investigators to specify clinically significant and meaningful magnitudes of win measures and probability of ties that are difficult to elicit based on prior published literature or preliminary data. In this paper, we provide sample size and power calculation formulas for the four win measures. To facilitate the formula-based sample size or power calculations, we provide formulas to compute overall win measures and overall probability of ties needed by using the specification of marginal win measures and marginal probability of ties that are readily available from clinical investigators or literature. The latter formulas provide a novel way to specify a meaningful and justifiable magnitude of win measures and the magnitude of probability of ties. Therefore, they can be readily used to evaluate the powers based on the number of multiple endpoints, the ordering, and types of endpoints. Our extensive simulation studies show that the power estimations based on these formulas are often like the simulated powers for any type of correlated hierarchical endpoints except for scenarios with very high correlations between endpoints. We illustrate the usefulness of our formulas by using data from three trials with different types of hierarchical endpoints.</p>\",\"PeriodicalId\":21879,\"journal\":{\"name\":\"Statistics in Medicine\",\"volume\":\"44 10-12\",\"pages\":\"e70096\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Statistics in Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/sim.70096\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MATHEMATICAL & COMPUTATIONAL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Statistics in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/sim.70096","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MATHEMATICAL & COMPUTATIONAL BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

获胜指标,如胜率、获胜几率、净收益和结果排序的可取性(DOOR),已成为临床研究中分级终点分析的流行方法。基于分层端点的win测量的样本量和功率计算通常基于模拟研究,这可能很麻烦。现有的样本量和功率公式要求研究人员指定临床显著和有意义的胜利测量和联系的概率,这些很难根据先前发表的文献或初步数据得出。在本文中,我们提供了四种获胜措施的样本大小和功率计算公式。为了便于基于公式的样本量或功率计算,我们提供了公式,通过使用临床研究人员或文献中现成的边际获胜措施和边际平局概率的说明,计算所需的总体获胜措施和总体平局概率。后一个公式提供了一种新的方式来指定一个有意义的和合理的大小的赢的措施和大小的概率平局。因此,它们可以很容易地用于基于多个端点的数量、顺序和端点的类型来评估幂。我们广泛的模拟研究表明,除了端点之间具有非常高相关性的情况外,基于这些公式的功率估计通常与任何类型相关分层端点的模拟功率相似。我们通过使用具有不同类型分层终点的三个试验的数据来说明公式的有用性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Sample Size and Power Calculations With Win Measures Based on Hierarchical Endpoints.

Win measures, such as win ratio, win odds, net benefit, and desirability of outcome ranking (DOOR), have become popular approaches for the analysis of hierarchical endpoints in clinical studies. Sample size and power calculations with win measures based on hierarchical endpoints are often based on simulation studies that can be cumbersome. Existing sample size and power formulas require investigators to specify clinically significant and meaningful magnitudes of win measures and probability of ties that are difficult to elicit based on prior published literature or preliminary data. In this paper, we provide sample size and power calculation formulas for the four win measures. To facilitate the formula-based sample size or power calculations, we provide formulas to compute overall win measures and overall probability of ties needed by using the specification of marginal win measures and marginal probability of ties that are readily available from clinical investigators or literature. The latter formulas provide a novel way to specify a meaningful and justifiable magnitude of win measures and the magnitude of probability of ties. Therefore, they can be readily used to evaluate the powers based on the number of multiple endpoints, the ordering, and types of endpoints. Our extensive simulation studies show that the power estimations based on these formulas are often like the simulated powers for any type of correlated hierarchical endpoints except for scenarios with very high correlations between endpoints. We illustrate the usefulness of our formulas by using data from three trials with different types of hierarchical endpoints.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Statistics in Medicine
Statistics in Medicine 医学-公共卫生、环境卫生与职业卫生
CiteScore
3.40
自引率
10.00%
发文量
334
审稿时长
2-4 weeks
期刊介绍: The journal aims to influence practice in medicine and its associated sciences through the publication of papers on statistical and other quantitative methods. Papers will explain new methods and demonstrate their application, preferably through a substantive, real, motivating example or a comprehensive evaluation based on an illustrative example. Alternatively, papers will report on case-studies where creative use or technical generalizations of established methodology is directed towards a substantive application. Reviews of, and tutorials on, general topics relevant to the application of statistics to medicine will also be published. The main criteria for publication are appropriateness of the statistical methods to a particular medical problem and clarity of exposition. Papers with primarily mathematical content will be excluded. The journal aims to enhance communication between statisticians, clinicians and medical researchers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信